2024-12-13 16:46:37
Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Senior US official: Russia has provided important assistance to Iran in fighter planes, missile defense and space technology.Sources: The attack on the Russian oil depot did not affect the oil transportation to Europe via Ukraine. Ukrainian industrial sources said on Wednesday that the Ukrainian attack on an oil depot in the Bryansk region of Russia at night did not affect the oil transportation to Europe via Ukraine. The Ukrainian military said on Wednesday that the warehouse was part of the "Friendship" oil export pipeline and a "fire" broke out after the air raid. The source said: "This attack has nothing to do with oil transportation because it is a facility to ensure the supply of diesel and petroleum products. Everything is going according to plan. "
Fenda Technology's daily limit today was 110 million yuan, and Fenda Technology's daily limit today was 6.402 billion yuan, with a turnover rate of 42.27%. After-hours data showed that the special seats of Shenzhen Stock Connect bought 104 million yuan and sold 118 million yuan, and the special seats of the two institutions sold 110 million yuan.Guosen Securities: The public offering of corporate bonds to professional investors was approved by the China Securities Regulatory Commission. Guosen Securities announced that the company had received the approval of the China Securities Regulatory Commission to publicly issue corporate bonds with a total face value not exceeding 20 billion yuan to professional investors. This issuance of corporate bonds shall be conducted in strict accordance with the prospectus submitted to Shenzhen Stock Exchange. The reply shall be valid within 24 months from the date of consent to registration, and the company may issue corporate bonds in installments within the validity period of registration.General Motors (GM): The unmanned business Cruise and GM Technical team will be merged, and the plan is expected to be completed in the first half of 2025. According to the priority of GM's capital allocation, GM will no longer fund Cruise's self-driving taxi development business.
Qujiang Wenlv: It received a warning letter from Shaanxi Supervision Bureau, and Qujiang Wenlv announced that the company received the Decision on Taking Measures to Issue Warning Letters to Xi 'an Qujiang Cultural Tourism Co., Ltd., Xie Xiaoning and Xi 'an Qujiang Tourism Investment Co., Ltd. issued by Shaanxi Supervision Bureau of China Securities Regulatory Commission on December 10, 2024. After investigation, the company delayed the disclosure of the major event that 8.23% of the company's shares held by the controlling shareholder Xi 'an Qujiang Tourism Investment Co., Ltd. were to be disposed of by the judiciary, which violated the relevant provisions of the Measures for the Administration of Information Disclosure of Listed Companies. According to Article 52 of the Measures, Shaanxi Supervision Bureau decided to take administrative supervision measures to issue warning letters to the company, Xie Xiaoning, the relevant responsible person, and Qujiang Travel Investment, the controlling shareholder. The company will seriously rectify, strengthen information disclosure and corporate governance, and improve the operation level and information disclosure quality.Today, these stocks changed their main positions to increase electronic stocks and sell computer stocks, with a large amplitude.-Today, there are 22 stocks in A shares with an amplitude of more than 20%; -N Boyuan, Shenhao Technology, Panda Dairy and other stocks are among the top in amplitude; The turnover rate is high-today, there are 58 A-shares with a turnover rate of over 30%; -N Boyuan, Giant Wheel Intelligence, Tianyu Digital and other stocks have the highest turnover rate; Main funds-today, the main funds flowed into electronics, communications, real estate, non-ferrous metals, light industry manufacturing and other sectors, and flowed out of computers, machinery and equipment, non-bank finance, power equipment, automobiles and other sectors; -vision china, Jianghuai Automobile, Woer Nuclear Materials, Xinyisheng and Runxin Technology have the largest net inflows, with net inflows of 749 million yuan, 699 million yuan, 693 million yuan, 626 million yuan and 622 million yuan respectively; -Oriental Fortune, Shanzi Hi-Tech, Leo, Straight Flush, and Tianyue Mathematics have the largest net outflows, with net outflows of 2.295 billion yuan, 1.237 billion yuan, 1.131 billion yuan, 872 million yuan and 871 million yuan respectively.Japanese manufacturers' confidence index turned negative to the central bank's forecast in December. A short-term survey in Reuters, Japan, found that Japanese manufacturers' business confidence deteriorated further in December due to concerns about US protectionist policies. The survey of 505 large Japanese non-financial enterprises showed that manufacturers' confidence index fell from 5 in November to -1 in December, which was the first time since last February, and the number of pessimists exceeded optimists for the first time in 10 months. The loss of business confidence may cast a shadow over the Bank of Japan's forecast. The Bank of Japan had previously predicted that a steady recovery driven by rising wages and consumption would help inflation reach the 2% target in a sustainable way and justify further interest rate hikes. Many manufacturing industries have reported that business confidence has declined. Among electronic machinery manufacturers, steel and non-ferrous metal manufacturers, pessimists far exceed optimists.